By: E.O. Iwalewa*, T. Roland , B. O. Aduloju, M. O. Ologe, A. O. Adepiti, S.A. Odediran, O. J. Iwalewa, E.M. Obuotor, J. I. Olawuni
Abstract: Drug combinations represent current treatment strategies in the management of malaria. Nitric oxide (NO) has been proposed to inhibit Plasmodium growth due to its parasite-scavenging activity thus the effects of various combinations of an NO inducer - anthraquinone (25-100 mg/kg, ANT), an NO donor - sodium nitroprusside (0.5 mg/kg, SNP) and NO inhibitor -nitro-L-arginine methyl ester (40 mg/kg, L-NAME) and their combination drugs were evaluated using the antimalarial curative model in Plasmodium berghei-infected mi…
Keywords: Nitric oxide; chloroquine; Plasmodium berghei; curative; drug combinations.
Int. J. Pharm. & Pharmacol. 2011, 2(1), 1-6;